Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
The Woodlands, TX
SEC filing record 1 source field available
Fiscal year end
31 December
LEXICON PHARMACEUTICALS, INC. has filed 1,396 SEC EDGAR filings since 09 Feb 2000

SEC filing history

Showing 751-775 of 994 matching filings.

Per page
25
Current page
31
3

PRIMARY DOCUMENT

Filing date
29 Jul 2014
Reporting date
24 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Jul 2014
Reporting date
07 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
08 Jul 2014
Reporting date
07 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

8-K

Filing date
08 Jul 2014
Reporting date
07 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

8-K

Filing date
08 May 2014
Reporting date
07 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2014
Reporting date
25 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2014
Reporting date
25 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2014
Reporting date
25 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2014
Reporting date
25 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2014
Reporting date
25 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2014
Reporting date
25 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2014
Reporting date
25 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2014
Reporting date
25 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2014
Reporting date
25 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

FORM 8-K

Filing date
24 Apr 2014
Reporting date
24 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-30111

AUTO-GENERATED PAPER DOCUMENT

Filing date
18 Mar 2014
Reporting date
31 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-30111

2014 PROXY

Filing date
14 Mar 2014
Reporting date
13 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-30111

DEFA14A

Filing date
14 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2014
Reporting date
28 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2014
Reporting date
28 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2014
Reporting date
28 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2014
Reporting date
28 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2014
Reporting date
28 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .